Results 181 to 190 of about 1,632,982 (236)

Gut microbiota and metabolomics reveal the combined effects of <i>Alpinia oxyphylla</i> fructus polysaccharide and nootkatone on chronic kidney disease via the "gut-kidney" axis. [PDF]

Front Pharmacol
Zhang R, Chen Y, Meng H, Jia A, Fu D, Lin X, Wang J, He J, Zhou Y, Li Y.   +9 more
europepmc   +1 more source

Metabolic abnormalities and reprogramming in cats with naturally occurring hypertrophic cardiomyopathy

ESC Heart Failure, Volume 12, Issue 2, Page 1256-1270, April 2025.
Abstract Background and aims The heart is a metabolic organ rich in mitochondria. The failing heart reprograms to utilize different energy substrates, which increase its oxygen consumption. These adaptive changes contribute to increased oxidative stress.
Qinghong Li, Max Homilius, Erin Achilles, Laura K. Massey, Victoria Convey, Åsa Ohlsson, Ingrid Ljungvall, Jens Häggström, Brittany Vester Boler, Pascal Steiner, Sharlene Day, Calum A. MacRae, Mark A. Oyama   +12 more
wiley   +1 more source

Asiatic acid from <i>Centella asiatica</i> alleviates renal fibrosis: coordinated modulation of the gut-kidney axis and retinol metabolism. [PDF]

Front Nutr
Zhu L, Xu Z, Chang X, Wu J, Chen S, Jiang Y, Guo J, Du Z, Chen H, Qiang S.   +9 more
europepmc   +1 more source

Ketogenic diet for infantile epileptic spasms

Epilepsia Open, EarlyView.
Abstract Approximately half of all cases of Infantile Epileptic Spasms Syndrome (IESS) do not respond to vigabatrin and hormonal therapies. There is no clear consensus as to the second‐line therapy for IESS. Ketogenic diet (KD) has emerged as an effective treatment for certain drug‐resistant epilepsies and in many cases of IESS.
Morris H. Scantlebury, Anamika Choudhary, Andy Cheuk‐Him Ng, Cezar Gavrilovici   +3 more
wiley   +1 more source

Microbiota-Gut-Kidney Axis and Targeted Therapeutic Strategies in Kidney Diseases. [PDF]

Int J Biol Sci
Sun ZH, Gong Q, Wang ZL, Li C, Wang JN, Yu JT, Ji ML, Zhang DF, Wei J, Xie SS, Zhou FJ, Li XY, Suo XG, Zhu Q, Jin J, Shao W, Pan P, Meng XM.   +17 more
europepmc   +1 more source

Indoxyl Sulfate in the Gut-Kidney Axis: Pathophysiology and Clinical Significance in CKD-Associated Colorectal Cancer. [PDF]

Toxins (Basel)
Shimizu H, Niwa T.
europepmc   +1 more source

The Gut-Kidney Axis in Uric Acid Nephropathy: Microbiota, Metabolic Crosstalk, and Translational Prospects. [PDF]

J Multidiscip Healthc
Liang J, Qiu Y, Fu T, Li J, Yang J, Tong Y.   +5 more
europepmc   +1 more source

Fertility counseling and preservation considerations in patients with gynecologic and non‐gynecologic BRCA and Lynch‐associated malignancies

International Journal of Gynecology &Obstetrics, EarlyView.
Abstract Lynch syndrome and BRCA‐mutation associated malignancies are fortunately rare. Affected patients have an increased risk of cancer diagnosis at a young age, often significantly overlapping with their reproductive years. In helping these patients, oncologists must navigate the following areas of care: cancer prevention, impact of cancer ...
Anna Weimer, Nadeem Abu‐Rustum, David Mutch, Mauricio Cuello, Angélica Fletcher, Hextan Y. S. Ngan, Nozomu Yanaihara, Rene Pareja, Christina Fotopoulou, Kenneth Ruzindana, Ka Yu Tse, Yana Zou, Neerja Bhatla, Ting‐Chang Chang, Munanchiso Ndukwe Iheme Jr, Jalid Sehouli, Nicole Conchin, Eva Chalas, Sarikapan Wilailak, Barbara Schmalfeldt, Alexander B. Olawaiye   +20 more
wiley   +1 more source

Chronic High‐Salt Intake Reprograms Metabolic Homeostasis Driven by Dietary Rice Varieties via Microbial and Metabolite Associations

iMetaMed, EarlyView.
Using a 2% salt diet and a 10‐month feeding to model chronic human sodium exposure, we found that black rice improved glucose tolerance and short‐chain fatty acids, but 2% salt inverted black rice's blood glucose benefits. White rice + 2% salt treatment uniquely increased short‐chain fatty acids.
Xiaofang Li, Fangyang Chen, Ping Chen, Yage Wang, Mengke Yuan, Zhuojun Li, Hao Chen, Zongkang Zhang, Kaikai Li   +8 more
wiley   +1 more source

The gut-kidney axis in chronic kidney disease: mechanisms, microbial metabolites, and microbiome-targeted therapeutics. [PDF]

Front Med (Lausanne)
Alobaidi S.
europepmc   +1 more source